Impact Emotional Intelligence Program on Opioid Relapse
NCT ID: NCT06207266
Last Updated: 2024-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2022-01-01
2023-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotional Intelligence in Patients With Addictive Disorder
NCT03521609
Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?
NCT06310668
Quality of Life of Caregivers of Addicts
NCT05089552
Nurse-Led Heart Math Training Program With Substance Use Disorder
NCT06437366
Single Session Class to Reduce Opioid Use in Chronic Pain
NCT03950791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The concept of emotional intelligent (EI) "the ability to perceive accurately, appraise and express emotion; the ability to access and generate feelings when they facilitate thought; the ability to understand emotion and emotional knowledge; and the ability to regulate emotions to promote emotional and intellectual growth", the ability to manage and regulate emotions in an effective manner and ability to be sufficiently optimistic, positive and self- motivated in order to set and achieve goals.
Most drug addicts possess hidden defects in their social skills, and do not have good relations with their peers. The other possible causes of orienting toward drugs are defects in problem solving, stress-management, and prevention from dangerous and impulsive behaviors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with opioid use disorder group with emotion intelligence program (n=20)
Participants with opioid use disorder group who had emotion intelligence program to increase aware about definition, component, how to deal with EI to reduce relapse rate.
emotion intelligence program
The programme was established using research that described emotional intelligence components and their applicability to patients suffering from substance abuse. it considers as awareness program.
Participants with opioid use disorder group without intelligence program (n=20).
Participants with opioid use disorder group who had traditional medical treatment only
No interventions assigned to this group
A healthy group (n=20) served as a control group.
A healthy group who did not have history of psychiatric illness or substance use.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
emotion intelligence program
The programme was established using research that described emotional intelligence components and their applicability to patients suffering from substance abuse. it considers as awareness program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in healthy groups: no history of psychiatric illness or substance use
Exclusion Criteria
18 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gellan Karamalllah Ramadan Ahmed
lecturer of psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
gellan Karamallah R Ahmed
Role: STUDY_DIRECTOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Nursing
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMOTION INTELLIGENCE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.